Stock BNTC BENITEC BIOPHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Benitec Biopharma Inc.

Equities

BNTC

US08205P2092

Delayed Nasdaq
Other stock markets
 14:37:35 15/05/2024 BST 		5-day change 1st Jan Change
8.63 USD +2.37% Intraday chart for Benitec Biopharma Inc. -0.12% +167.18%
05-13 Benitec Biopharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
04-22 Benitec Biopharma Inc. announced that it has received $40.000019 million in funding from a group of investors CI

Evolution of the average Target Price on Benitec Biopharma Inc.

Price target over the last 5 years

History of analyst recommendation changes

7ab5d7aa19f8b4fa977.Es4RhfIXQI72iDg67Ithzp_Xr6sYGfcp86itQm9j1v8.W4VAsbtECf_B2Vl0pckypequ-vl_bc9gkPLjEzgSmZI_iVPLw2Qx-c79YQ~8e755f07fa2fb8cc52ba2bf0ba5e6d1a

Analyst Recommendations on Benitec Biopharma Inc.

JMP Securities Adjusts Benitec Biopharma's Price Target to $8 From $6, Keeps Market Outperform Rating MT
JMP Securities Starts Benitec Biopharma at Market Outperform With $4 Price Target MT
HC Wainwright Adjusts Price Target on Benitec Biopharma to $4 From $10, Reiterates Buy Rating MT
HC Wainwright Initiates Benitec Biopharma at Buy With $10 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
12.73 AUD
Average target price
24.91 AUD
Spread / Average Target
+95.63%
High Price Target
24.91 AUD
Spread / Highest target
+95.63%
Low Price Target
24.91 AUD
Spread / Lowest Target
+95.63%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Benitec Biopharma Inc.

JMP Securities
HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BNTC Stock
  4. Consensus Benitec Biopharma Inc.